Dr M. Mumtaz Alam
Professor
Jamia Hamdard
Delhi
Expertise:
Pharmacology and Pharmacy
141
Publications
1
Projects
5513
Scopus Citations
4848
CrossRef
23 Years 1 Month Total Experience
Scopus
5,513
Citations
36
h-index
CrossRef
4,848
Citations
33
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
No Data Found
There is currently nothing to display here.
Community & Membership
CAS Committee for Promotion from Assistant Professor to Associate Professor
ChairmanCDOE
Deputy DirectorDelhi Pharmacy Council
Registered PharmacistIndian Science Congress
Life MemberIndian Pharmaceutical Association
Life MemberAssociation of Pharmaceutical Teachers of India
Life MemberIndian Society of Analytical Scientist
Life MemberAssociation of Pharmacy Professionals
Life MemberSociety of Pharmaceutical Education and Research
Life MemberPersonal Details
Doctor of Philosophy
N/A
Professor
Jan 2020 – Present
Jamia Hamdard
Associate Professor
Jan 2017 – Dec 2019
Jamia Hamdard
Assistant Professor (Grade-III)
Jan 2013 – Dec 2016
Jamia Hamdard
Assistant Professor (Grade-II)
Jan 2010 – Dec 2013
Jamia Hamdard
Assistant Professor (Grade-I)
Jan 2006 – Dec 2009
Jamia Hamdard
| Department of Pharmaceutical Chemistry
Lecturer
Aug 2003 – Jan 2006
Jamia Hamdard
Medical and Health Sciences
Scholarly Work
Virtual screening using docking and molecular dynamics of estradiol-pyrimidine analogs against Mpro and ACE2 receptors: A possible therapeutic tool for COVID-19
OtherDesign and Synthesis of cyanopyrimidine derivatives as novel lysine specific demethylase 1 (LSD1) inhibitor for treatment of cancer
Synthesis, characterization and evaluation of Pyrimidine-Thiazolidinedione derivatives as a therapeutic intervention for diabetes and associated secondary complications
Studies on Hybrid Heterocyclic Compounds: Design, Synthesis and Anticancer activity
Design and synthesis of Pyrimidine based anticancer and anti-inflammatory agents
Investigating the Cellular and Molecular Mechanisms of Neurotherapeutics against Cerebral Ischemia Reperfusion Injury
Identification and biological evaluation of prolyloligopeptidase inhibitors for Alzheimer disease
Synthesis and biological evaluation of novel Pyrazol-4-acrylic acid analogues as potential anticancer and anti-inflammatory agents
Studies on pyrazole based antiprotozoal compounds: their synthesis and metabolic evaluation
Design and synthesis of pyrimidine and pyrazoline derivatives as anticancer agents
Synthesis and antimalarial activity of pyrazoline derivatives
Design and development of some new five membered heterocyclic compounds as novel antimycobacterial agents
Computational, design, synthesis and characterization of novel DPP-IV inhibitors as antidiabetic agents
No Data Found
There is currently nothing to display here.
Scholarly Publications
Search for new pharmacophore as antimalarial agent: Synthesis and antimalarial activity of some 2(3H)-furanones bearing quinoline moiety
Scopus: 3
A Review on the Synthesis and Anticancer Potentials of Imidazothiazole Derivatives
Unravelling the role of dipeptidyl peptidases-8/9 (DPP-8/9) in inflammatory osteoporosis: a comprehensive study investigating chrysin as a potential anti-osteoporotic agent
Open AccessMechanistic insights toward progress in alogliptin beyond glycemic control: translational perspective
Open AccessOsteogenic effect of alogliptin in chemical-induced bone loss: a tri-modal in silico, in vitro, and in vivo analysis
Open AccessLevocabastine ameliorates cyclophosphamide-induced nephrotoxicity in Swiss albino mice via NF-κB/cleaved caspase-3/TGF-β signaling pathways
Levocabastine ameliorates cyclophosphamide-induced cardiotoxicity in Swiss albino mice: Targeting TLR4/NF-κB/NLRP3 signaling pathway
Pharmacophore-guided review of EGFR-targeted anticancer drugs with gefitinib as a reference
Showing 1 to 8 of 141 publications